PRESS RELEASE published on 02/04/2026 at 07:35, 8 months 26 days ago ONWARD Medical Announces First Participant Enrolled in Global Pivotal Study Evaluating ARC-IM System to Address Blood Pressure Instability After Spinal Cord Injury ONWARD Medical enrolls first participant in global pivotal study evaluating ARC-IM System for blood pressure instability after spinal cord injury. Empower BP targets SCI individuals with injuries at spinal cord levels C2-T6 ONWARD Medical Spinal Cord Injury ARC-IM System Empower BP Blood Pressure
BRIEF published on 11/24/2025 at 08:23, 11 months 6 days ago ONWARD Medical franchit des étapes clés au troisième trimestre 2025 Performance Financière Publications Scientifiques Système ARC-EX Étude Empower BP Étapes Réglementaires
BRIEF published on 11/24/2025 at 08:23, 11 months 6 days ago ONWARD Medical Achieves Key Milestones in Q3 2025 Financial Performance Regulatory Milestones ARC-EX System Empower BP Study Scientific Publications
PRESS RELEASE published on 11/24/2025 at 08:18, 11 months 6 days ago ONWARD Medical Drives Strong US ARC-EX Adoption and Achieves Important Scientific and Regulatory Milestones in Q3 2025 ONWARD Medical achieves strong US ARC-EX adoption and significant milestones in Q3 2025, including regulatory approvals and financial highlights Financial Highlights Neurotechnology Regulatory Milestones ONWARD Medical ARC-EX
BRIEF published on 10/28/2025 at 18:04, 1 year ago ONWARD Medical clôture un placement privé de 50,85 millions d'euros Placement Privé ONWARD Medical Thérapie De La Moelle Épinière Neurotechnologie Cotation Sur Euronext
BRIEF published on 10/28/2025 at 18:04, 1 year ago ONWARD Medical Closes EUR 50.85 Million Private Placement Private Placement Neurotechnology Euronext Listing ONWARD Medical Spinal Cord Therapy
PRESS RELEASE published on 10/28/2025 at 17:59, 1 year ago ONWARD Medical Publishes Closing of Bookbuild Offering ONWARD Medical N.V. announces closing of private placement with institutional investors amounting to EUR 50,850,000. New shares listed and traded on Euronext Private Placement Euronext Neurotechnology ONWARD Medical N.V. EUR 50,850,000
BRIEF published on 10/24/2025 at 07:59, 1 year ago ONWARD Medical Secures Over EUR 50 Million in Capital Increase Capital Increase Neurotechnology EUR 50 Million ONWARD Medical Spinal Cord Injury
BRIEF published on 10/24/2025 at 07:59, 1 year ago ONWARD Medical obtient une augmentation de capital de plus de 50 millions d'euros Augmentation De Capital 50 Millions D'euros ONWARD Medical Neurotechnologie Lésion De La Moelle Épinière
PRESS RELEASE published on 10/24/2025 at 07:54, 1 year ago ONWARD Medical Successfully Raises Over EUR 50 Million in Capital Increase ONWARD Medical successfully raises over EUR 50 million in capital increase through private placement with institutional investors like Ottobock and Invus, extending cash runway to 2026 Private Placement Capital Increase Institutional Investors EUR 50 Million ONWARD Medical
Published on 10/30/2026 at 23:35, 3 hours 33 minutes ago Prospect Ridge Announces Closing of Critical Metals Flow-through Unit Private Placement
Published on 10/30/2026 at 23:30, 3 hours 38 minutes ago Revolve Enters into Definitive Agreement to Acquire Three Project, 6 MW Battery Storage Portfolio in Ontario
Published on 10/30/2026 at 20:47, 6 hours 21 minutes ago CoTec Holdings Corp. Comments on Share Trading
Published on 10/30/2026 at 19:00, 8 hours 8 minutes ago Electric Royalties Ltd. Announces Application for Warrant Extension
Published on 10/30/2026 at 15:30, 11 hours 38 minutes ago Bluejay Diagnostics Announces 1-for-4 Reverse Stock Split
Published on 10/30/2026 at 22:49, 4 hours 19 minutes ago EQS-Adhoc: STRATEC SELLS LOSS-MAKING BUSINESS, RECOGNIZES IMPAIRMENTS, AND AMENDS GUIDANCE
Published on 10/30/2026 at 18:38, 8 hours 30 minutes ago EQS-Adhoc: Starcom Holding AD publishes Interim Q3 2026 Financial Report
Published on 10/30/2026 at 23:00, 4 hours 8 minutes ago BIOPHYTIS REPORTS FIRST- HALF 2026 RESULTS AND PROVIDES AN UPDATE ON ITS STRATEGY
Published on 10/30/2026 at 23:00, 4 hours 8 minutes ago Biophytis publie les résultats du premier semestre 2026 et fait le point sur sa stratégie
